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Background: MicroRNAs (miRNAs) can post-transcriptionally regulate gene expression and have been shown to
be critical regulators to the fine-tuning of epithelial immune responses. However, the role of miRNAs in bovine
responses to E. coli and S. aureus, two mastitis causing pathogens, is not well understood.
Results: The global expression of miRNAs in bovine mammary epithelial cells (MAC-T cells) challenged with and
without heat-inactivated Staphylococcus aureus (S. aureus) or Escherichia coli (E. coli) bacteria at 0, 6, 12, 24, and 48 hr was
profiled using RNA-Seq. A total of 231 known bovine miRNAs were identified with more than 10 counts per million in at
least one of 13 libraries and 5 miRNAs including bta-miR-21-5p, miR-27b, miR-22-3p, miR-184 and let-7f represented more
than 50% of the abundance. One hundred and thirteen novel miRNAs were also identified and more than one third of
them belong to the bta-miR-2284 family. Seventeen miRNAs were significantly (P < 0.05) differentially regulated by the
presence of pathogens. E. coli initiated an earlier regulation of miRNAs (6 miRNAs differentially regulated within the
first 6 hrs post challenge as compared to 1 miRNA for S. aureus) while S. aureus presented a delayed response. Five
differentially expressed miRNAs (bta-miR-184, miR-24-3p, miR-148, miR-486 and let-7a-5p) were unique to E. coli
while four (bta-miR-2339, miR-499, miR-23a and miR-99b) were unique to S. aureus. In addition, our study revealed a
temporal differential regulation of five miRNAs (bta-miR-193a-3p, miR-423-5p, miR-30b-5p, miR-29c and miR-un116)
in unchallenged cells. Target gene predictions of pathogen differentially expressed miRNAs indicate a significant
enrichment in gene ontology functional categories in development/cellular processes, biological regulation as well as
cell growth and death. Furthermore, target genes were significantly enriched in several KEGG pathways including
immune system, signal transduction, cellular process, nervous system, development and human diseases.
Conclusion: Using next-generation sequencing, our study identified a pathogen directed differential regulation of
miRNAs in MAC-T cells with roles in immunity and development. Our study provides a further confirmation of the
involvement of mammary epithelia cells in contributing to the immune response to infecting pathogens and suggests
the potential of miRNAs to serve as biomarkers for diagnosis and development of control measures.
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Mastitis is an infectious disease of the mammary gland that
has been considered as one of the most economically
important diseases in the dairy industry for several decades
[1]. Mastitis can be caused by a variety of bacteria
including Gram-negative Escherichia coli (E. coli) and
Gram-positive Staphyloccucus aureus (S. aureus) [2].
The mastitis caused by E. coli and other Gram-negative
bacteria is often clinical with an acute and severe
inflammation and the pathogens may be eventually
cleared by the immune system within days or with
antibiotic treatment [3,4]. In contrast, infection with
Gram-positive bacteria like S. aureus often causes mild
mastitis and the clearance of the pathogens by antibiotics
is often ineffective [5].
Efforts at mastitis control include understanding
host response mechanisms to infecting pathogens and de-
velopment of appropriate control strategies. Transcriptomic
as well as proteomic profilings have shown a marked
difference in the response of host to E. coli and S. aureus
bacteria. Transcriptomic studies on bovine mammary
epithelial cells in vitro challenged with mastitis pathogens
and/or mammary gland tissues collected after intramam-
mary infection revealed very different mechanisms in host
innate immune responses to pathogens [6-8]. Differential
cytokines and chemokines (at protein level) and other
immune response proteins were also observed in bovine
mammary epithelial cells and tissues or milk, in response
to E. coli and S. aureus [4,9,10].
Recently, an endogenous noncoding small RNA known
as microRNA (miRNA) has been shown to be involved in a
wide variety of biological processes such as development,
differentiation, apoptosis and viral infection. The role of
miRNA in the regulation of the innate and acquired
immune response has been well reviewed [11-14]. It
was shown that miR-155 promotes the production of
TNF-α in human embryonic kidney cells (HEK-293),
suggesting the positive role of miR-155 to modulate
the release of inflammatory mediators [15]. Recent studies
on human epithelial cells infected by a protozoan parasite
(Cryptosporidium parvum) revealed the up-regulation of
let-7i or miR-27b. While let-7i directly regulates the
expression of toll-like receptor 4 (TLR4) [16], miR-27b
targets KH-type splicing regulatory protein (KSRP) to
coordinate TLR4-mediated epithelial immune responses to
pathogens [17], indicating that miRNA may act as a critical
regulator in epithelial immune responses. In addition, it
was suggested that miRNA may modulate epithelial
immune responses at every step of the innate immune
network, including production and release of cytokines/
chemokines, expression of adhesion and costimulatory
molecules [18]. It has been clearly demonstrated that
bovine mammary epithelial cells mount a robust immune
response to the presence of bacterial pathogens [19-21].However, how miRNAs modulate this robust immune
response by the bovine mammary epithelial cells to the
presence of the mastitis pathogens, E. coli and S. aureus
bacteria, is poorly understood. Furthermore, studies
elucidating the regulatory roles of miRNA in bovine
immunity and infection are few. A recent study using
quantitative real time PCR technique revealed differ-
ential expression of five inflammation related miRNAs
(miR-9, miR-125b, miR-155, miR-146a and miR-223) after
stimulation of bovine monocytes with lipopolysaccharide
(LPS) and S. aureus enterotoxin B [22]. Using the same
technique, four miRNAs (bta-miR-181a, miR-16, miR-31
and miR-223) out of 14 miRNAs associated with regula-
tion of innate immunity and mammary cell function were
shown to be differentially regulated in bovine mammary
tissue challenged with Streptococcus uberis (S. uberis) [23].
These studies suggest roles of miRNAs in bovine
mammary gland immunity but the extent of information is
limited by the technique used. Increasingly, more robust
techniques like microarray and next-generation sequencing
are finding applications in the elucidation of miRNAs in
immunity [24,25]. In particular, next-generation sequen-
cing has the ability to profile the expression of both known
and novel miRNAs with high resolution and accuracy and
to distinguish miRNAs that are very similar in sequence as
well as isomiRs [26]. Only two studies to date have used
next-generation RNA sequencing to study the regulatory
roles of miRNAs upon bacterial or viral infections in
bovine [25,27]. Using RNA sequencing, 21 miRNAs
were detected as significantly differentially expressed
upon infection of bovine primary epithelial cells with
S. uberis, as well as a unique miRNA profile in response to
a Gram-positive bacterial infection [25]. However, more
information is needed to understand the roles of miRNAs
in modulating bovine mammary gland infections for
their effective application as biomarkers of mastitis or
as therapeutic agents.
To investigate the role of miRNA in host defense to two
mastitis pathogens, miRNA expression in bovine mammary
epithelial cells (MAC-T) challenged with heat-inactivated
Gram-negative E. coli stain P4 or Gram-positive S. aureus
strain Smith CP bacteria were characterized by next-
generation sequencing at different time points (6, 12, 24 or
48 hr) following challenge and at 0, 6, 12, 24 or 48 hr
without challenge. The next-generation sequencing tech-
nology allowed simultaneous detection of known and
novel bovine miRNAs, and global miRNAs expression as




Thirteen small RNA libraries were constructed and
sequenced simultaneously. A total of 15,315,312 high-quality
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quences ranging from 18 to 30 nucleotides were obtained
after adaptor trimming, accounting for 80.1% of all
small RNA (sRNA) sequences. Alignment with miRBase
(Release 19) revealed that miRNAs were highly enriched
in all libraries. Of the 18 to 30 nucleotide sRNA fraction,
more than three quarters (76.02%) of them were identified
as known bovine miRNAs, while only a small number
(< 2%) aligned to bovine tRNAs, rRNAs and snoRNAs.
The remaining reads were other sRNAs including novel
bovine miRNAs (~0.2%), loop sequences of miRNA
precursors and sequencing artifacts (Figure 1A). The
majority of reads from sRNAs and known miRNAs
were 20 to 24 nucleotides in length (comprising 89.4%
and 96.6% of their total number, respectively). Dominant
reads of sRNAs or known miRNAs were 22 nucleotides in
length (~50%), followed by 23, 24 or 20 nucleotides, and
lastly 21 nucleotides (Figure 1B, C).
In total, we identified 231 known bovine miRNAs with
more than 10 counts per million (CPM) in at least one
library. Among them, 18 highly expressed miRNAs
accounted for 78.55% of the total reads of identified
known miRNAs (Table 1). The top five highly expressed
miRNAs were bta-miR-21-5p, miR-27b, miR-22-3p,
miR-184 and let-7f, accounting for 16.02%, 15.18%,
8.37%, 5.45% and 5.01% of total known miRNA reads,
respectively.
Identification of novel miRNAs and miRNA candidates
With the high-throughput sequencing data, miRDeep2
[28] generated a score for each known miRNA and novel
miRNA. The score of 5.0 yielded a signal-to-noise ratio
of 16.2 [28] and was used as cut-off for novel miRNA
prediction (Additional file 1: Table S1.1). A total of 114
novel miRNA hairpins were identified (Additional file 2:Figure 1 Detected small RNAs. A pie graph showing the relative abunda
RNAs or miRNAs (B); frequency distribution of each size (18–30 nts) of sma
indicates known bovine miRNAs in miRBase (Release 19).Table S2). Moreover, 186 hairpins with lower scores
(0–4.9) but having more than 10 total counts were
further analyzed and 5 or 153 of them were defined
as precursors of novel miRNAs or miRNA candidates,
respectively (Additional file 3: Table S3). Although almost
all miRNAs have a variety of isoforms, most of the known
miRNAs detected or undetected by miRDeep2 (Additional
file 1: Table S1.2 and Additional file 1: Table S1.3) were
within the size range of 20 to 24 nucleotides. Moreover, a
false precursor of bta-miR-532 predicted by miRDeep2
(Additional file 1: Table S1.2) contained a star miRNA of
17 nucleotides in length, indicating that a precursor
generating a short miRNA may have a high false positive
rate. Therefore, precursors which form mature miRNAs
< 20 nucleotides in length were not further analyzed.
In total, five homologs of known miRNA precursors from
other animal species and ten reversely complementary to
known bovine miRNA precursors were identified to
generate 24 novel miRNAs (Table 2, Additional file 2:
Table S2 and Additional file 3: Table S3). We also
found an ortholog of bta-miR-222 (bta-miR-222b,
Table 2, Additional file 3: Table S3). In addition, more
than one third of novel or candidate miRNA precursors
(41/114, 65/153, respectively) were found to be clustered
together and have a high similarity to those of bta-mir-
2284 family in sequences (Additional file 2: Table S2,
Additional file 3: Table S3 and Additional file 4: Figure S1).
The remaining 62 novel miRNA precursors were
found to produce 56 mature miRNAs which are less
conserved to any known miRNA in miRBase (Release 19,
Additional file 2: Table S2).
Time effect on miRNA expression in MAC-T cells
Considering that miRNAs play roles in almost all biological
processes, we hypothesized that the expression of miRNAsnce of different classes of small RNAs (A); size distribution of small
ll RNAs or all known miRNAs based on all reads (C). miRNA here only
Table 1 Top expressed miRNAs in bovine MAC-T cells with or without challenge with E. coli or S. aureus bacteria
miRNA ID Total no.
of reads
Ratio*
All samples Control group E. coli group S. aureus group
bta-miR-21-5p 1494737 16.02% 15.89% 16.18% 16.07%
bta-miR-27b 1416234 15.18% 14.65% 15.46% 15.77%
bta-miR-22-3p 780733 8.37% 8.61% 8.38% 7.95%
bta-miR-184 508224 5.45% 5.65% 5.27% 5.30%
bta-let-7f 467126 5.01% 4.83% 4.94% 5.39%
bta-miR-205 424274 4.55% 4.56% 4.67% 4.39%
bta-miR-92a 363202 3.89% 3.74% 4.02% 4.01%
bta-miR-182 362632 3.89% 3.60% 3.87% 4.41%
bta-miR-31 261303 2.80% 2.92% 2.80% 2.60%
bta-let-7a-5p 190668 2.04% 2.19% 1.81% 2.05%
bta-miR-222 172392 1.85% 1.88% 1.84% 1.80%
bta-let-7i 166440 1.78% 1.73% 1.75% 1.92%
bta-miR-221 141821 1.52% 1.57% 1.51% 1.44%
bta-miR-26a 129420 1.39% 1.45% 1.39% 1.28%
bta-miR-148a 123204 1.32% 1.24% 1.40% 1.37%
bta-miR-27a-3p 118012 1.26% 1.34% 1.26% 1.14%
bta-miR-186 104935 1.12% 1.12% 1.15% 1.10%
bta-miR-191 103301 1.11% 1.08% 1.13% 1.12%
Total 7328656 78.55% 78.04% 78.84% 79.11%
*Ratio refers to the total number of reads of a miRNA as compared to all reads of known bovine miRNAs detected in this study (miRBase Release 19).
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MAC-T cells with or without pathogenic bacteria. The
global expression of miRNAs at different time points and
under treatments were profiled and the correlations
between libraries were performed with the normalized
counts of all detected miRNAs (CPM >10 in at least one
library). The correlations between libraries were very high
(Additional file 5: Figure S2), suggesting that only a limited
number of miRNAs might be significantly regulated during
the 48 hrs of cell challenge with mastitis pathogens. The
lowest correlation was found between 0 hr and 48 hrs in
control samples (R2 = 0.961), indicating that the expression
of miRNA might be significantly regulated over time.
Therefore, differentially expressed miRNAs between
different time points and 0 hr in control cells were
analyzed using DEseq, an R/Bioconductor package [29]
method to compare differential expression based on
sequence counts. We observed that five miRNAs
(bta-miR-193a-3p, miR-423-5p, miR-30b-5p, miR-29c
and miR-un116) were differentially expressed (P < 0.05) in
at least two time points in control cells as compared to
0 hr (Figure 2). The expression of bta-miR-193a-3p was
the most regulated over time, increasing lineally and
reaching 8.03 fold increase (P < 0.0001) within 48 hrs of
cell growth. The expression of bta-miR-30b-5p and
bta-miR-29c also increased over time but to a lessermagnitude as compared to bta-miR193a-3p. The expression
of bta-miR-423-5p was highest at 6 hrs (P < 0.001) and
returned to 0 hr level by 24 hrs (Figure 2). Conversely,
the expression of bta-miR-423-5p and bta-miR-un116
decreased with time. The expression of bta-miR-193a-3p
and bta-miR-423-5p in control cells was further validated
by qRT-PCR. Both miRNAs were significantly up-regulated
and reached a peak at 12 hrs, although no change larger
than 2-fold was found between any two time points
(Additional file 6: Figure S3).
Effect of pathogenic E. coli or S. aureus bacteria on miRNA
expression in MAC-T cells
To determine the effect of E. coli and S. aureus bacteria
on miRNA expression in MAC-T cells during the
48 hr incubation period, we compared the expression
of miRNAs at each time point to control samples at
the same time point. The expression of 17 miRNAs
were differentially affected (Table 3) by the presence of
pathogenic bacteria in MAC-T cells. Within 6 hrs of the
presence of E. coli, the expression of 6 miRNAs in MAC-T
cells was significantly altered (P < 0.05), three were down
regulated (bta-miR-193a-3p, miR-30c and miR-30b-5p)
while three were up-regulated (bta-miR-365-3p, miR-184
and miR-24-3p) (Table 3). With time, the number of
differentially expressed miRNAs in the presence of E. coli
Table 2 A partial list of novel miRNAs identified in bovine MAC-T cells with or without challenge with E. coli or S. aureus bacteria




5Score Mature reads Mature sequence Size Star reads Star sequence4 Size Precursor coordinate
bta-miR-1842-5p eca-mir-1842 eca-miR-1842 1180.4 2,172 uggcucugugaggucggcuca 21 142 agcaggccugucagggcguug 21 25:1744660..1744720:-
bta-miR-219-2-3p ssc-mir-219 ssc-miR-219 68.9 103 agaguugagucuggacgucccg 22 20 ugauuguccaaacgcaauuc 20 23:7335349..7335412:-
bta-miR-664-3p ssc-mir-664 ssc-miR-664-3p 68.5 70 uauucauuuaucucccagccuaca 24 59 caggcuaggagaaaugauuggau 23 16:24379875..24379936:-
bta-miR-6516-5p gga-mir-6516 9.6 10 uuugcaguaacaggugugaac 21 9 aucauguaugauacugcaaaca 22 19:55419754..55419817:+
bta-mir-2964a-3p bta-mir-219-1′ hsa-miR-2964a-3p 20.7 27 agaauugcguuuggacaaucagu 23 5 gauguccagccacaauucucg 21 11:98997166..98997230:+
bta-miR-3548-3p bta-mir-200a′ rno-miR-3548 6.6 2 cagcacuguccgguaagauguc 22 2 caucguuaccagacaguguuaga 23 16:52521338..52521399:+
bta-miR-194-1′-3p bta-mir-194-1′ 30.4 56 acauggaguugcuguuacaaucg 23 3 aaguaacagcaucuccacugga 22 16:24306044..24306105:+
bta-miR-486′-5p bta-mir-486′ 27.8 48 cccgguacugagcugacccgag 22 4 ucggggcagcucaguacaggac 22 27:36261849..36261912:+
bta-miR-374a′-5p bta-mir-374a′ bta-miR-374a-3p 26.1 50 uuacaauacaaccugauaagug 22 1 acuuaucagguuguauuaua 20 X:81951234..81951283:-
bta-miR-763′-3p bta-mir-763′ 6.8 8 ucccagcuggucauuaauccu 21 3 gaauuaauggcuggcugggagg 22 5:48164035..48164101:+
bta-miR-191′-5p bta-mir-191′ bta-miR-191 5.5 40 gaacgaaauccaagcgcagcug 22 0 gcugcuuuugggauuccguugcc 23 22:51543481..51543545:-
bta-miR-1388′-3p bta-mir-1388′ bta-miR-1388-5p 1.8 405 uucucagguuggacaguccuga 22 0 cgggcugacaaaccugagauug 22 13:54375941..54376002:-
bta-miR-374b′-5p bta-mir-374b′ bta-miR-374-3p 1.4 60 ugauaauacaaccugauaagug 22 0 cuuagcagguuguauuauaucc 22 X:82023929..82023981:-
bta-miR-194-2′-3p bta-mir-194-2′ bta-miR-194 4.8 10 cacauggaguugcuguuaca 20 0 uaacagcagccccacugga 19 29:43731473..43731526:-
bta-miR-590-3p eca-mir-590 1.4 13 uaguuuuauguguaagcucguu 22 0 cgagcuuauucacagaaguaca 22 25:33713356..33713419:-
bta-miR-222b-3p bta-miR-222 4.9 20 ugcuacaucuggcuacugga 20 0 ggguggacgcuguguggcugagc 23 10:78769129..78769183:+
1“`”represents the antisense of miRNA precursor; the star sequence of miR-219-2 is miR-219-5p in miRBase (Release 19);
2The top known miRNA precursor (miRBase Release 19) aligns to novel precursor with > 70 identity and > 75 sequence length;
3The top known miRNA (miRBase Release 19) matches novel miRNA covering > 90 identity and > 90 sequence length;
4Sequence here only shows the dominant one and the star sequence that was absent was predicted by miRDeep2.



















Figure 2 Five differentially expressed miRNAs in control cells over time as compared to 0 hr.
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cantly altered. Conversely in S. aureus challenged cells, only
one miRNA, bta-miR-2339, responded significantly to the
presence of S. aureus bacteria in the first 6 hrs by showing a
4.56 fold up regulation (P < 0.05) as compared to control
cells. Furthermore, the expression of more miRNAs became
affected by the presence of S. aureus with increasing
time (4 miRNAs at 16 hrs, 5 at 24 hrs and 4 at 48 hrs).
The three miRNAs (bta-miR-193a-3p, miR-30c and
miR-30b-5p) that were significantly down regulated or
one miRNA (bta-miR-365-3p) that was significantlyTable 3 Significantly differentially expressed miRNAs in MAC




miRNA ID Fold change log2Fold change P-Valu
6 h bta-miR-193a-3p 0.37 −1.416 4.30E-0
bta-miR-365-3p 1.52 0.608 4.47E-0
bta-miR-184 1.27 0.343 0.019
bta-miR-24-3p 1.33 0.411 0.0229
bta-miR-30c 0.75 −0.406 0.024
bta-miR-30b-5p 0.71 −0.502 0.048
12 h bta-miR-21-3p 1.85 0.886 1.27E-0
bta-miR-148a 1.43 0.516 0.0200
bta-miR-423-5p 0.69 −0.545 0.0205
bta-miR-92a 1.37 0.454 0.0389
24 h bta-miR-423-5p 1.58 0.658 1.21E-0
bta-miR-21-3p 1.68 0.751 2.43E-0
bta-let-7a-5p 0.69 −0.544 3.43E-0
bta-miR-184 0.76 −0.394 0.0326
bta-miR-un5 0.52 −0.940 0.0444
48 h bta-miR-486 1.94 0.955 6.46E-0
bta-miR-193a-3p 0.64 −0.650 0.0183
*Fold change values are as compared to controls at same time points.up regulated within 6 hrs of E. coli presence only
showed a retarded significant down regulation by 24
or 48 hrs (bta-miR-193a-3p, 30c and 30b-5p) or up
regulation (bta-miR-365-3p) by 48 hrs in the presence of S.
aureus. Both pathogens presented significant up-regulation
of bta-miR-21-3p at 12 hr (1.85 and 1.79 fold change in E.
coli and S. aureus, respectively) and 24 hr (1.68 and 1.55
fold change in E. coli and S. aureus, respectively) post
challenge. In contrast, the expression of bta-miR-21-5p,
the other arm of bta-mir-21 and the top expressed
miRNA in this study (Table 1) remained constant at these-T cells between treatments (challenged with E. coli or
S. aureus
e miRNA ID Fold change log2Fold change P-Value
6 bta-miR-2339 4.56 2.188 0.0427
3
3 bta-miR-21-3p 1.79 0.836 4.20E-03
bta-miR-423-5p 0.67 −0.578 0.0168
bta-miR-499 0.06 −3.998 0.0300
bta-miR-92a 1.36 0.449 0.0428
3 bta-miR-193a-3p 0.62 −0.700 7.78E-03
3 bta-miR-23a 1.46 0.550 0.0137
3 bta-miR-99b 0.69 −0.540 0.0154
bta-miR-21-3p 1.55 0.636 0.0191
bta-miR-un5 0.47 −1.077 0.0238
4 bta-miR-193a-3p 0.20 −2.302 4.49E-08
bta-miR-365-3p 2.49 1.315 6.87E-04
bta-miR-30c 0.55 −0.871 0.0191
bta-miR-30b-5p 0.53 −0.904 0.0241
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and 24 hrs respectively, and 1.13 and 1.06 fold change in
S. aureus at 12 and 24 hrs respectively). The most
regulated miRNA after infection was bta-miR-193a-3p
(−2.67 fold change in E. coli at 6 hrs and −4.93 fold change
in S. aureus at 48 hrs). It should be noted that in most
cases, different miRNAs were differentially regulated at
different time points indicating a rapid temporal change
in the response pattern of miRNAs to the presence of
bacteria. Furthermore, the differential expression pattern
of five miRNAs (bta-miR184, miR-24-3p, miR-148,
miR-486 and bta-let-7a-5p) were unique to E. coli while
four (bta-miR-2339, miR-499, miR-23a and miR-99b) were
unique to S. aureus. The expression of bta-miR-21-3p,
miR-365-3p, miR-193a-3p, miR-423-5p and miR-486 in
challenged cells was further confirmed by qPCR. The
expression trends of these five miRNAs were in most
cases similar to results obtained by deep-sequencing
(Table 4). For example, bta- miR-193a-3p and miR-365-3p
for E. coli at 6 h, miR-21-3p and miR-423-5p for E. coli at
12 h, miR-423-5p for E. coli at 24 h, miR-193a-3p for E.
coli at 48 h, miR-21-3p for S. aureus at 24 h, and
miR-193a-3p and miR-365-3p for S. aureus at 48 h
were similarly differentially expressed (P < 0.05) withTable 4 Results of qPCR validation of the expression of five m
with E. coli or S. aureus bacteria) and controls at same time p
Time
points
miRNA ID E. coli
Fold change* SE




















*Fold change values are as compared to controls at same time points.
#Bolded numbers indicate the significance with P < 0.05.both methods. Surprisingly however, was the observed
significant differential expression of all five miRNAs
in S. aureus challenged cells at 6 h with qPCR method as
opposed to non-significant regulation with next-generation
sequencing. Similarly, different expression patterns of
bta-miR-21-3p for E. coli at 24 h and S. aureus at 12 h,
miR-486 for E. coli at 48 h and miR-423-5p for S. aureus
at 12 h between the two methods were also observed.
Enriched KEGG pathways and GO functional categories of
predicted gene targets of differentially expressed miRNAs
in MAC-T cells challenged with E. coli or S. aureus bacteria
Target gene prediction of 16 out of 17 miRNAs (target
genes for bta-miR-un5 not determined) differentially
regulated by the presence of pathogens indicates that
about 5169 genes may be regulated by these miRNAs
(Additional file 7: Table S4). Gene ontology (GO)
functional annotation showed that the target genes of
differentially regulated miRNAs were significantly (P < 0.05)
enriched in different functional groups, namely; cellular
process, developmental process, localization, biological
regulation, cellular component organization, cell death,
multicellular organismal process, metabolic process, estab-
lishment of localization and cell growth (Table 5). TheiRNAs in MAC-T cells between treatments (challenged
oints
S. aureus
P-Value# Fold change SE P-Value
0.021 0.630 0.054 0.048
0.508 3.478 0.365 0.006
0.014 0.612 0.040 0.042
0.042 2.018 0.096 0.008
0.036 1.616 0.046 0.008
0.911 0.601 0.085 0.010
0.017 1.062 0.272 0.819
0.568 0.994 0.106 0.962
0.004 0.812 0.106 0.111
0.032 1.630 0.342 0.142
0.017 1.327 0.171 0.140
0.092 1.222 0.066 0.040
0.879 0.890 0.096 0.478
0.046 1.304 0.297 0.336
0.545 0.867 0.119 0.480
0.020 0.336 0.026 0.021
0.679 1.105 0.080 0.385
0.006 2.809 0.204 0.008
0.130 2.894 0.258 0.010
0.835 2.189 0.415 0.071
Table 5 Significantly enriched GO (gene ontology) functional annotation of predicted target genes of differentially
expressed miRNAs during E. coli or S. aureus challenge of MAC-T cells
GO functional annotation miRNA # genes *P-value
(**Benjamini P-Value)
miRNA # genes P-value
(Benjamini P-Value)
Biological adhesion Bta-miR-23a 58 0.038 (0.11) - - -
Biological regulation Bta-miR193a-3p 159 0.002 (0.039) Bta-miR-24-3p 287 0.010 (0.070)
Bta-miR365-3p 142 5.5E-5 (3.9E-4) Bta-miR-148a 356 1.7E-8 (1.3E-7)
Bta-miR-30b-5p/30c 642 4.4E-6 (3.2E-5) Bta-miR-23a 565 4.0E-9 (4.2E-8)
Bta-miR-499 135 0.045 (0.11) Bta-miR-92a 441 7.2E-10 (1.6E-8)
Bta-miR-99b 31 0.007 (0.060) - - -
Cellular component organization Bta-miR-30b-5p/30c 235 2.4E-4 (0.001) Bta-miR-2339 46 0.002 (0.016)
Bta-let-7a-5p 182 0.040 (0.120) Bta-miR-23a 192 0.004 (0.016)
Bta-miR-499 60 0.001(0.008) Bta-miR-92a 144 0.016 (0.049)
Bta-miR-148a 127 9.4E-4 (0.005) Bta-miR-184 22 0.006 (0.080)
Cellular process Bta-miR193a-3p 207 0.009 (0.096) Bta-miR-24-3p 411 1.1E-6 (2.3E-5)
Bta-miR423-5p 337 0.034 (0.160) Bta-miR-148a 468 2.1E-9 (4.7E-8)
Bta-miR365-3p 180 5.7E-4 (0.003) Bta-miR-2339 143 0.002 (0.020)
Bta-miR-30b-5p/30c 889 1.1E-10 (2.5E-9) Bta-miR-23a 766 1.1E-13 (2.4E-12)
Bta-let-7a-5p 732 1.3E-5 (2.5E-4) Bta-miR-486-5p 140 0.007 (0.067)
Bta-miR-499 198 8.2E-6 (1.6E-4) Bta-miR-92a 567 2.0E-7 (1.4E-6)
Bta-miR-99b 37 0.036 (0.100) - - -
Death Bta-miR193a-3p 21 0.038 (0.190) Bta-miR-24-3p 35 0.046 (0.220)
Bta-miR-30b-5p/30c 70 0.031 (0.083) Bta-miR-21-3p 7 0.044 (0.930)
Bta-let-7a-5p 61 0.026 (0.087) Bta-miR-92a 47 0.037 (0.084)
Bta-miR-499 21 0.014 (0.045) - - -
Developmental process Bta-miR193a-3p 71 0.028 (0.190) Bta-miR-24-3p 151 1.0E-5 (1.0E-4)
Bta-miR423-5p 114 0.024 (0.150) Bta-miR-148a 182 3.7E-9 (4.1E-8)
Bta-miR365-3p 80 5.8E-7 (1.3E-5) Bta-miR-2339 57 7.1E-4 (0.015)
Bta-miR-30b-5p/30c 312 9.1E-8 (1.0E-6) Bta-miR-23a 272 2.2E-8 (1.5E-7)
Bta-let-7a-5p 241 0.001 (0.008) Bta-miR-486-5p 56 0.001 (0.022)
Bta-miR-499 74 4.1E-4 (0.004) Bta-miR-92a 212 7.8E-8 (8.5E-7)
Bta-miR-99b 19 0.002 (0.030) - - -
Establishment of localization Bta-miR423-5p 110 3.4E-4 (0.007) Bta-let-7a-5p 205 0.004 (0.011)
Bta-miR-30b-5p/30c 243 9.9E-4 (0.004) Bta-miR-92a 159 0.003 (0.009)
Growth Bta-miR-99b 4 0.016 (0.088) Bta-miR-23a 20 0.026 (0.088)
Localization Bta-miR423-5p 119 8.8E-4 (0.009) Bta-miR-148a 147 0.001 (0.005)
Bta-miR-30b-5p/30c 280 7.0E-5 (3.9E-4) Bta-miR-2339 49 0.015 (0.078)
Bta-let-7a-5p 233 7.2E-4 (0.008) Bta-miR-92a 182 4.8E-4 (0.002)
Bta-miR-499 68 0.002 (0.008) - - -
Locomotion Bta-miR193a-3p 14 0.049 (0.200) Bta-miR-92a 31 0.030 (0.080)
Bta-miR-499 17 0.002 (0.009) - - -
Metabolic process Bta-miR365-3p 139 9.6E-4 (0.004) Bta-miR-148a 334 0.001 (0.006)
Bta-let-7a-5p 538 0.001 (0.008) Bta-miR-23a 559 1.8E-6 (9.7E-6)
Bta-miR-99b 30 0.025 (0.081) Bta-miR-92a 395 0.039 (0.084)
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Table 5 Significantly enriched GO (gene ontology) functional annotation of predicted target genes of differentially
expressed miRNAs during E. coli or S. aureus challenge of MAC-T cells (Continued)
Multicellular organismal process Bta-miR365-3p 94 2.3E-5 (2.4E-4) Bta-miR-24-3p 167 0.050 (0.190)
Bta-miR-30b-5p/30c 372 0.001 (0.004) Bta-miR-148a 196 0.005 (0.015)
Bta-miR-499 84 0.027 (0.077) Bta-miR-92a 258 2.2E-5 (1.2-E4)
Bta-miR-99b 20 0.023 (0.095) - - -
*P-Value: The significance of gene-term enrichment with a modified Fisher’s Exact Test.
**Benjamini P-Value: Globally corrects enrichment p-values in order to control family-wide false discovery rate.
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the cellular and developmental process followed by target
genes of 11 miRNAs in localization and of 10 miRNAs in
biological regulation. Interestingly, several KEGG pathways
were significantly (P < 0.05) enriched by target genes of 14
of the 17 differentially expressed miRNAs (Table 6 and
Additional file 8: Table S5). Notably, pathways of the
immune system, signal transduction, cellular processes,
nervous system, development and pathways in human
diseases, especially cancer were significantly enriched by
target genes of at least 4 miRNAs (Table 6).
Discussion
Next-generation sequencing technologies have not only
enabled the detection of more lowly expressed miRNAs
and novel miRNA discovery, but also accurate profiling
of the expression of miRNAs at a high-throughput level.
Using deep-sequencing, we have identified a number of
novel bovine miRNAs and revealed a differential regulation
of miRNAs in MAC-T cells challenged with E. coli or
S. aureus bacteria, thus suggesting the regulation of
miRNAs in host response to these mastitis pathogens.
The number of miRNAs deposited in miRBase has
increased exponentially in recent years and high
throughput sequencing has contributed to almost all
sequences submitted to miRBase after 2007 [30]. However,
high throughput sequencing generates millions of reads per
sample and requires powerful and accurate computational
methods to mine known and novel miRNAs. Several
computational software packages such as miRDeep
[28], MIReNA [31], miRanalyzer [32], and miRTRAP
[33] have been developed to identify miRNAs from
high-throughput data. Our study used a combination of
miRDeep2 and Blastn and identified 113 novel miRNAs in
MAC-T cells. It is notable that computational based
approaches may over-predict novel miRNAs and our data
remain to be validated by further studies.
It is necessary to give a consistent and unique gene name
for each novel miRNA. The nomenclature of miRNA has
been well described previously [30,34,35]. However, the
annotation of miRNAs still presents misperceptions in
some instances. Some recently identified miRNAs and
their precursors are reversely complementary to previ-
ously known miRNAs and precursors. For example,hsa-mir-103a and hsa-mir-103b (miRBase Release 19)
are paired (reversely complementary) but are usually
thought to be distinguished by 1 or 2 nucleotide differences
in their nucleotide sequences. Here we added a symbol “`”
after miRNA to represent the antisense of a known miRNA
precursor (Table 2), i.e. hsa-mir-103 and mir-103′instead of
mir-103a, b, respectively. In addition and to the best of our
knowledge, there is no established criterion that defines
conserved miRNAs. We suggest that a novel miRNA is
homologous or orthologous if: 1) it precursor aligns to a
known miRNA precursor with > 70% identity and > 75%
sequence coverage; or 2) it has > 90% identity and > 90%
length coverage with a known miRNA as well as same arm
location on the precursor. Previously, only sequence
similarity was taken into account for the annotation
of conserved miRNAs and disparities have been
known to occur. For example, bta-miR-193a [36]
(miRBase Release 19), generated from bta-mir-193a-2,
is reversely complementary to bta-miR-193a-3p from
1 to 19 nucleotides but not correctly named. Using
this criterion, one miRNA candidate identified in this
study (un219, Additional file 3: Table S3) was aligned to
bta-miR-222. Un219 is at the same arm as bta-miR-222
on the precursor and therefore named as bta-miR-222b
(Table 2, Additional file 3: Table S3).
Only a few miRNAs (Table 1) were highly expressed,
accounting for 78.55% of all known bovine miRNAs
detected. This observation is consistent with a recent
study that detected similar miRNAs expression levels in
bovine primary mammary epithelial cells infected with
Streptococcus uberis and also, seven of the top expressed
miRNAs in that study [25] are the same as in this study.
Most of the detected top expressed miRNAs are
conserved in human, mouse, and bovine, and belong to
several miRNA families, vis, miR-31, miR-26a, miR-27a-
3p/27b, let-7a-5p/7f/7i, miR-21-5p, miR-22-3p, miR-184,
miR-186, miR-191, miR-205 and miR221/222. In particular,
several of these highly expressed miRNAs are known to
play roles in growth and immunity. The top expressed
miRNA, bta-miR-21-5p in this study, was also the most
highly expressed miRNA in human blood monocytes
challenged with Mycobacterium leprae and also found
to negatively regulate the vitamin D-dependent antimicro-
bial pathway in leprosy [37]. miR-21-5p has been shown to
Table 6 KEGG (Kyoto encyclopedia of genes and genomes) pathways significantly enriched by target genes of 14 out
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MAPK signaling pathway X X X X X X X
ErbB signaling pathway X X X X
Wnt signaling pathway X X X X X X
TGF-beta signaling pathway X X X X




ECM-receptor interaction X X
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Cell cycle X X X X
P53 signaling pathway X X X X
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Focal adhesion X X X X X
Endocrine system




GnRH signaling pathway X X X
Melanogenesis X X X
Nervous system
Long term potentiation X X X X
Neurotrophin signaling pathway X X X X X X






Pathways in cancer X X X X X X X X X
Colorectal cancer X X X X X X X X
Pancreatic cancer X X X X
Bladder cancer X
Prostate cancer X X X X X X
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Table 6 KEGG (Kyoto encyclopedia of genes and genomes) pathways significantly enriched by target genes of 14 out
of 17* differentially expressed miRNAs during E. coli or S. aureus challenge of MAC-T cells (Continued)
Small cell lung cancer X X X
Non-small cell lung cancer X X X X
Thyroid cancer X
Renal cell carcinoma X X X X
Endometrical cancer X X
Glioma X X X X X
Melanoma X X X X
Type II diabetes mellitus X X
Chronic myeloid leukemia X X X X
Acute myeloid leukemia X X
*Results for miR-21-3p were ignored because only few target genes out of 78 were non-significantly enriched in two pathways (Neurotophin signaling pathway- 3 genes
and Ubiquitin mediated pathway- 3 genes). Similarly, only 3 genes each out of 88 target genes for miR-184 were enriched (P > 0.05) in two pathways, Chronic myeloid
leukemia and Prostate cancer and were ignored. The target genes for miR-un5, a newly identified miRNA in this study were not determined.
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targeting the programmed cell death protein 4 (PDCD4)
and to promote the expression of interleukin 10 (IL-10)
[38]. Further evidence of the immune capacity of miR-21
was from the study of Narducci et al. [39] who provided
in vitro evidence for involvement of miR-21, miR-214 and
miR-486 in cell survival in Sézary syndrome in humans.
It has been recently shown that the level of immune and
development related miRNAs, including miR-27b, were
significantly higher in colostrum than in mature milk
[40]. Up-regulation of miR-27b by LPS was found to
destabilize proliferator-activated receptor γ1 (PPARγ1)
mRNA which is often associated with chronic inflam-
matory diseases [41]. In addition, miR-27b was reported
to target KSRP and increase iNOS mRNA stability for
host’s defense against cryptosporidial infection [17], fur-
ther supporting a role for this miRNA in immunity.
Therefore, the highly expressed miR-21-5p and miR-27b
in mammary epithelial cells in this study might be asso-
ciated with a function in immunity.
Five miRNAs were found to be significantly regulated
during the 48 hr cell incubation without pathogens. It is
not surprising owing to their involvement in almost all
biological processes as demonstrated by GO functional
annotation of the target genes of three (bta-miR-193a-3p,
miR-423-5p and miR-30b-5p) of these miRNAs. GO
functional annotation of target genes of bta-miR-193a-3p
and miR-30b-5p showed enriched genes related to cell
growth and death, e.g. growth arrest specific gene 1
(GAS1), myeloid cell factor 1 (MCL1, also BCL2 related),
BCL2-like 11 (apoptosis facilitator) and programmed cell
death 10 (PDCD10). GAS1 has been shown to be involved
in growth suppression through blocking of entry to
S-phase and also prevents cycling of normal and
transformed cells [42,43]. Also, involvement of MCL1
and PDCD10 in the regulation of apoptosis and cellsurvival has been demonstrated [44-46]. It is well known
that cells enter the stationary phase after reaching
confluence. Additionally, we used fetal bovine serum
(FBS) free media, known to inhibit proliferation, during
the 48 hr period of cell incubation. The up-regulation of
miR-193a-3p and miR-30b-5p may play regulatory roles in
cell death which need to be further confirmed in the
context of mastitis.
Out of the 231 known and 113 novel miRNAs identified
in this study, only 17 showed differential expression after
challenge of MAC-T cells with E. coli or S. aureus bacteria,
which may look small considering the large number of
identified miRNAs. It is probable that observed miRNA
expression profiles in response to heat inactivation of
bacteria in this study may be different than expression
elicited by live bacterial cells. In a recent study [47], a
substantially different miRNA expression profile emerged
from killed virulent bacilli as compared to live active
bacteria thus suggesting an active influence of living
bacteria on cellular miRNA metabolism. However, our
results on response to heat inactivated S. aureus are in line
with literature information whereby 21 miRNAs were
shown to be differentially expressed after challenge of
bovine primary mammary epithelia cells with live S.
uberus (Gram-positive) bacteria [25]. Regardless, further
studies on the miRNA expression patterns during infec-
tion with live and active bacteria is necessary to verify the
miRNA expression variation identified between these
two species. In addition, there were discrepancies in
expression pattern of some low abundant miRNAs
during the infection detected by sequencing as compared
to RT-PCR. This difference may be due to the pooling
approach used for library preparation and subsequent
sequencing, as well as the relative low sequence reads
which may limit the proper detection of the low abundant
miRNAs by miRNA-Seq. Furthermore, the miRNA
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different and also regulated differently. miRNA expression
profile has been shown to vary between mature milk and
colostrum [48], between lactating and non-lactating
mammary glands [49] and, between organs (lung,
brain, liver and spleen) and whole blood [50]. During
the onset of mastitis and subsequent progression, the
whole system reacts by recruiting immune cells into
the mammary gland to help combat infection. These
immune cells and other factors, including resident
factors and cells in the mammary gland work in concert
to ward off infection. It should be noted here that, the
mammary epithelial cells used in this study only consti-
tutes a small portion of that army of cell types that secrete
defence factors against invading pathogens. Thus, the
present findings portray only the role of epithelial cells
derived miRNAs in the fight against mastitis pathogens,
which may be different from the holistic picture that can
be obtained after examination of all players. In profiling
the transcriptome of S. uberis induced mastitis, funda-
mental differences were revealed between immune gene
expression in the mammary gland and in a primary cell
culture model thus demonstrating the complexity of the
bovine mammary gland immune response to an infecting
pathogen, and also indicating that a coordinated response
exists between resident, recruited, and inducible immune
factors [51]. Furthermore, transcriptomics comparisons
between MAC-T cells and mammary tissue during late
pregnancy and peak lactation showed a larger overall simi-
larity in gene expression between MAC-T cells and lactat-
ing than non-lactating mammary tissue [52]. Despite these
demonstrated differences [51,52] and or similarities [52],
our results showed similarity between highly expressed
miRNA profiles with primary bovine mammary epithelial
cells challenged with Gram positive bacteria [25] and non-
challenged mammary gland tissues (data not shown) thus
indicating that the MAC-T cell is still a valuable tool to
study mammary gland biology. Importantly, the findings
from our study show the positive involvement of mam-
mary epithelia cells in contributing to the immune re-
sponse to infecting pathogens.
Furthermore, our study has demonstrated that E. coli initi-
ated a stronger response at the early hours of infection as
demonstrated by the differential response of six miRNAs
within the first six hours of cell challenge with E. coli bacteria
as opposed to only one differentially expressed miRNA in
the presence of S. aureus. By 48 hrs, two miRNAs were dif-
ferentially regulated in E. coli challenged cells while in S. aur-
eus cells, more miRNAs were implicated with time.
Furthermore, three of the miRNAs that responded signifi-
cantly to the presence of E. coli at 6 hrs post infection only
showed a differential response in S. aureus cells by 24 or
48 hrs. Interestingly, our study shows that a different set
of five miRNAs (miR-184, miR-24-3p, miR-148, miR-486 and let-7a-5p) were unique to E. coli bacteria while
another set of four (miR-2339, miR-499, miR-23a and
miR-99b) were unique to S. aureus bacteria. Our data
therefore demonstrate a differential response pattern of
MAC-T cells to Gram-negative E. coli, as compared to
Gram-positive S. aureus. Mastitis caused by pathogenic li-
gands from Gram-positive or Gram-negative bacteria
usually elicits different response patterns from the host
thus leading to different degrees of mastitis. Our data
supports the intense immune reaction usually caused by
E. coli mastitis, which often leads to acute mastitis. On
the contrary, the slower initial response of miRNAs
to S. aureus bacteria may support the slow progression of
mastitis caused by this type of bacteria. Differential re-
sponse patterns of miRNAs to Gram-positive and Gram-
negative bacteria have been demonstrated previously
[22,49]. Furthermore, our data is supported by previous
studies that have demonstrated pathogen-dependent
differences of host (mammary gland) responses to other
immune factors (genes and proteins) [4,7-10].
It is notable that predicted gene targets of most of
the differentially expressed miRNAs in response to
pathogens in this study are significantly enriched for
GO functionally annotated roles like developmental
process, cellular process, localization, biological regulation,
cellular component organization, multicellular organismal
process, cell death, metabolic process, establishment of
localization and growth, thus supporting the involvement
of these miRNAs in numerous developmental and
physiological processes, including disease development.
This also goes a long way to portray the significant roles
of miRNAs in supporting the mammary gland in its
growth and productive capacities as well as defense
capabilities. Interestingly, pathway analysis of miRNA
predicted gene targets, showed significant enrichments in
KEGG pathways already associated with host response to
different diseases. Notably, many of the KEGG pathways
significantly enriched by differentially expressed miRNA
target genes in this study have been previously associated
to mammary gland responses to bacterial pathogens in
bovine [6,23,25]. For example, gene targets of five differen-
tially expressed miRNAs (miR-365-3p, miR-30b-5p,
miR-30c, let-7a-5p and miR-23a) were enriched for path-
ways in immune system (B-cell receptor signaling pathway,
chemokine signaling, T-cell receptor signaling and Fc
gamma R-mediated phagocytosis). These miRNAs are
amongst several miRNAs with demonstrated roles in
immunity. A recent study showed that the expression
levels of three miRNAs including miR-23a were signifi-
cantly higher in breast cancer with lymph node metastasis,
compared with that from patients without lymph node
metastasis or normal tissue and also that the expression
of the miR-23a/24-2/27a cluster promoted mammary
carcinoma cell migration, invasion, and hepatic metastasis,
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activation of p44/42 MAPK (mitogen-activated protein
kinase) [53]. The MAPK pathway was highly activated in
mammary cells and tissues challenged with S. uberis
[23,25]. In addition, the role of Let-7 miRNA family in
immunity is well established. The let-7 miRNA family
was identified as the common denominator of Salmonella-
regulated miRNAs in macrophages and epithelial cells,
thus suggesting that repression of let-7 relieves cytokine
IL-6 and IL-10 mRNAs from negative post-transcriptional
control, thus establishing a paradigm of miRNA-mediated
feed-forward activation of inflammatory factors when
mammalian cells are targeted by bacterial pathogens
[54]. Let-7b/d/e miRNAs, were recently shown to be
differentially regulated in infected (S. uberis) bovine
mammary cells [25].
Conclusion
Using deep sequencing, we characterized the miRNome of
bovine mammary epithelia cells (MAC-T cells) challenged
with heat inactivated E. coli or S. aureus bacteria and
detected 231 known bovine miRNAs and 113 novel
miRNAs, and also a pathogen dependent differential
regulation of miRNAs. In particular, E. coli elicited an
earlier differential regulation of miRNAs as opposed
to a delayed regulation by S. aureus. Highly expressed and
differentially regulated miRNAs have demonstrated roles
in diverse biological processes as well as in immunity.
GO and KEGG pathway analysis showed significant
enrichments of predicted target genes of differentially
regulated miRNAs in different functional groups (e.g. cellu-
lar process, developmental process, biological regulation,
cell death, etc.) and KEGG pathways of the immune system,
signal transduction, cellular process, nervous system, devel-
opment and pathways in cancer and other human diseases.
Importantly, our study provides further confirmation of the
involvement of mammary epithelia cells in contributing
to the immune response to infecting pathogens and a
potential role for miRNAs as biomarkers in early diagnosis
of mastitis and in development of control measures.
Methods
Cell culture and bacteria challenge
Cell culture and bacteria challenge were carried out as pre-
viously described with some modifications [4]. Briefly,
MAC-T cells (a bovine mammary epithelial cell line) were
seeded at a concentration of 1.5 × 105 cells in a 6 well cell
culture plate (BD Biosciences, Mississauga, Ontario,
Canada) and grown in a growth medium for 24 hours at
37°C in 5% CO2 humidified incubator. The growth medium
contained DMEM and RPMI 1640 (Wisent, St-Bruno,
Quebec, Canada) at a concentration of 1:1, 10% fetal
bovine serum (FBS) (Wisent), 10 μL/mL ITS (insulin-
transferrin-selenium solution) (Wisent), and 1% antibioticantimycotic solution (100×) (Wisent). At 85% confluence,
the growth medium was changed for infection medium
(same as the growth medium without FBS) and cells were
allowed to grow for another 24 hr period before infection
with bacterial pathogens.
Escherichia coli (E. coli) strain P4 and Staphylococcus
aureus (S. aureus) strain Smith CP were the infection
agents. Bacteria were initially grown overnight on Luria
Bertani (LB) agar (E. coli) or on tryptic soy agar (TSA)
(S. aureus) aerobically in a humidified incubator at 37°C. A
single colony of S. aureus was transferred to a 50 mL
conical tube containing 20 ml of tryptic soy broth (TSB)
and incubated at 37°C in an open air shaker at 225 RPM.
Similarly, a single colony of E. coli was grown the same way
in LB broth. The bacteria were grown until an OD600nm of
0.6 was reached and then plated in triplicates on their
respective media to confirm the number of bacteria per
mL. Growth of bacteria and subsequent manipulations
were carried out in the biosafety containment level II
laboratory of the Dairy and Swine Research and
Development Centre of Agriculture and Agri-Food Canada,
Sherbrooke, following institutional safety procedures.
Prior to infection, cells in 6 wells were individually
trypsinized and counted using the Countess® Automated
Cell Counter (Life Technologies, Burlington, Ontario,
Canada). The two bacterial strains were then diluted to
achieve a concentration enabling a ratio of 10 bacteria to
1 MAC-T cell in the infection medium and then heat
inactivated at 63°C for 30 minutes to prevent overgrowth
during the period of cell challenge. After refreshing
infection medium, each triplicate cell well representing
different time points (6, 12, 24 and 48 hr) and each bacterial
strain was challenged with the infection medium containing
bacteria to achieve an infection rate of 1:10. Non-
challenged triplicates (control) for each time point (0, 6, 12,
24 and 48 hr) were also included. Uninfected cells were
treated with the same volume of heat inactivated infection
media without bacteria. After 0, 6, 12, 24 and 48 hr, the
media were removed, cells washed once in Hank’s balanced
salt solution 1X (HBSS 1X; Wisent) without trypsinisation,
harvested in 1 mL of lysis/binding buffer (mirVana miRNA
Isolation Kit, Ambion Inc., Austin, TX, USA) and stored
at −80°C until RNA extraction.
Total RNA isolation and library construction
Total RNA was extracted using the mirVana miRNA
Isolation Kit (Ambion®, life technologies, USA) following
manufacturer’s protocol. The concentration and purity
of the isolated RNA was checked by NanoDrop®
ND-1000 Spectrophotometer (NanoDrop Technologies
Inc., Wilmington, DE, USA). The quality of RNA was
further assessed with the RNA 6000 Nano Labchip Kit
using the Agilent 2100 Bioanalyzer (Agilent Technologies,
CA, USA). All the 39 RNA samples had a RNA integrity
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further analysis.
Equal amounts (330 ng) of total RNA from triplicate
samples at the same time point were pooled to construct
small RNA library using the TruSeq Small RNA Sample
Preparation kit (Illumina, San Diego, CA, USA) according
to the manufacturer’s instruction. PCR amplification was
performed for 13 cycles. In total, 13 small RNA libraries
were constructed and pooled in equal amounts for gel
purification and sequencing. Sequencing was carried out
on the HiScan SQ system (Illumina) using the TruSeq™
SBS kit v3 (50 cycles, Illumina). Real-time analysis and
base calling was done using the HiSeq Control Software
Version 1.4.8 (Illumina).
Small RNA sequence analysis
Low-quality reads were removed from the raw reads
using CASAVA 1.8 based on chastity. After trimming
the 3′ adaptor sequence by a perl script (“clip_adapters.
pl”) provided by miRDeep2 software (version 2.0.0.5),
small RNA reads with 18–30 nts in length from all
libraries were extracted and pooled to identify known
and novel miRNAs using miRDeep2 with the default
parameters [28]. All reads were aligned to the bovine gen-
ome (2009, UMD3.1) with Bowtie (allowing 1 mismatch)
[55] and reads that mapped to bovine rRNAs, tRNAs, and
snoRNAs in the Rfam RNA family database [56] were
discarded. The remaining reads were scored by miRDeep2
as known or potential novel bovine miRNAs. Small RNAs
that mapped only to genomic repeat loci were removed.
The lowest score cut-off of 5 that yielded a signal-to-noise
ratio of 16.2 [28] was used for novel miRNA predication
and small RNAs with higher scores than threshold were
regarded as potential novel miRNAs. Furthermore, small
RNAs having lower scores than cut-off but more than 10
reads in total [30] were further analyzed as miRNA
candidates. Small RNAs < 20 nucleotides in size were
ignored because of higher false-positive discovery
rates and the remaining novel miRNAs and miRNAs
candidates were further annotated using Blastn [57]
(word size = 6). Conserved novel miRNAs were classified
as homologous known miRNAs or orthologous known
bovine miRNAs and named according to the following
guidelines: (1) it matches > 90% identity and > 90% of the
length of a known animal miRNA (miRBase Release 19),
or (2) it precursor aligns to any precursor of a known
miRNA with > 70% identity and > 75% sequence coverage
[58]. In addition, a huge bovine specific miRNA family
(bta-miR-2284, miRBase Release 19) containing more than
80 members, shows very high similarity in their precursor
sequences. Therefore, novel miRNAs were regarded as
new members of bta-miR-2284 family if their precursors
were clustered by CLUSTAL W [59] with bta-miR-2284
precursors. Non-conserved novel miRNAs were alsonamed and inputted into miRBase, while the remaining
miRNA candidates that didn’t follow any of the categories
above were not further analyzed.
The expression of miRNAs (known and novel miRNAs)
for each library was calculated by miRDeep2 using the
Quantifier module [28]. Reads that mapped equally well
to the positions of two or more mature miRNAs were
divided equally to the read counts of those mature miRNAs.
To investigate the regulation of miRNAs in MAC-T cells in
response to stimulation by pathogens, miRNA expression
in challenged cells at different time points were compared
to expression in unchallenged cells (controls) at the same
time point using DEseq and raw reads as suggested [29].
DEseq allows a P-value to be determined in the absence of
any available biological replicates, by treating the two
conditions as replicates, under the assumption that
only a small proportion of transcripts are differentially
expressed [29]. Similarly, miRNA regulation in control
cells over time was determined by comparing expression
levels at different time points and 0 hr.
Target gene prediction and pathway analysis
The putative target genes of differentially expressed
miRNAs were predicted using Ingenuity Pathway
Analysis (IPA) software (Ingenuity Systems Inc., Redwood
City, CA, USA). IPA uses a miRNA target filter that
depends on experimentally validated gene-miRNA inter-
actions from TarBase database (http://diana.cslab.ece.ntua.
gr/tarbase) and miRecords (http://mirecords.biolead.org/),
and the presence of conserved 8mer and 7mer sites on 3
prime untranslated regions (3′UTR) of genes that match
the seed region of each miRNA from TargetScan
(http://www.targetscan.org). Additionally, manually curated
findings within the IPA knowledgebase are also used.
Predictions returned by IPA are either experimentally
validated interactions, high or moderate interactions
between the 8mer/7mer seed regions of miRNA that
match sites on 3′UTR of genes. In this study, only
genes showing high predictions and experimentally
validated interactions were further analysed. Predicted gene
targets were imputed into the Database for Annotation,
Visualization and Integrated Discovery (DAVID version
6.7, http://david.abcc.ncifcrf.gov/) for gene ontology (GO)
functional annotation and pathway analysis.
Quantitative PCR and data analysis
Five differentially expressed miRNAs (bta-miR-193a-3p,
miR-423-5p, miR-21-3p, miR-365-3p and miR-486) were
validated by quantitative RT-PCR using TaqMan® miRNA
Assays following manufacturer’s recommendations
(Applied Biosystems, Foster City, CA, USA). Briefly,
cDNA was reversely transcribed from 10 ng of total
RNA using 5 × specific miRNA RT primer for each
miRNA. PCR products were amplified from cDNA samples
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were detected on an ABI StepOnePlus Real-time PCR
System (Applied Biosystems). Triplicates for each reaction
were performed. Bovine miR-192 was used as internal
control since it was the best stable miRNA detected by
sequencing (C.V =5.14%). The relative expression of target
miRNA was calculated following the formula:
ΔCttarget miRNA =Cttarget miRNA–Ctinternal control. The con-
trol group at each time point was selected as a calibrator in
each comparison group for the relative quantification. The
relative expression of miRNA in a sample normalized to
internal control and relative to the calibrator was calculated
as follows: Relative expression target miRNA = 2
-ΔΔCt, where
ΔΔCt =ΔCt target miRNA, sample -ΔCttarget miRNA, calibrator.
T-test (SAS version 9.2, 2008) was used to compare the
difference between each comparison group. Significant
differential expression was declared at P < 0.05.
Availability of supporting data
All the sequencing data sets supporting the results in this
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nlm.nih.gov/geo/). The data are accessible through GEO
Series accession number GSE51979 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE51979).
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